Role of Matricellular Proteins in Disorders of the Central Nervous System

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2016 Nov 24

PMID 27878658

Citations 30

Authors

A R Jayakumar

A Apeksha

M D Norenberg

Affiliations

Soon will be listed here.

Abstract

Matricellular proteins (MCPs) are actively expressed non-structural proteins present in the extracellular matrix, which rapidly turnover and possess regulatory roles, as well as mediate cell-cell interactions. MCPs characteristically contain binding sites for other extracellular proteins, cell surface receptors, growth factors, cytokines and proteases, that provide structural support for surrounding cells. MCPs are present in most organs, including brain, and play a major role in cell-cell interactions and tissue repair. Among the MCPs found in brain include thrombospondin-1/2, secreted protein acidic and rich in cysteine family (SPARC), including Hevin/SC1, Tenascin C and CYR61/Connective Tissue Growth Factor/Nov family of proteins, glypicans, galectins, plasminogen activator inhibitor (PAI-1), autotaxin, fibulin and perisostin. This review summarizes the potential role of MCPs in the pathogenesis of major neurological disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, ischemia, trauma, hepatic encephalopathy, Down's syndrome, autism, multiple sclerosis, brain neoplasms, Parkinson's disease and epilepsy. Potential therapeutic opportunities of MCP's for these disorders are also considered in this review.

Citing Articles

Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study.

Janus A, Dumas D, Le Douce J, Marie S, Pasculli G, Bambury P Neurol Ther. 2024; 14(1):357-377.

PMID: 39708220 PMC: 11762061. DOI: 10.1007/s40120-024-00691-w.

Microangiopathy in temporal lobe epilepsy with diffusion MRI alterations and cognitive decline.

Liu J, Binding L, Puntambekar I, Patodia S, Lim Y, Mryzyglod A Acta Neuropathol. 2024; 148(1):49.

PMID: 39377933 PMC: 11461556. DOI: 10.1007/s00401-024-02809-8.

Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson's disease.

Tatenhorst L, Maass F, Paul H, Dambeck V, Bahr M, Dono R Sci Rep. 2024; 14(1):5005.

PMID: 38424123 PMC: 10904781. DOI: 10.1038/s41598-024-54800-8.

Increased thrombospondin-1 levels contribute to epileptic susceptibility in neonatal hyperthermia without seizures via altered synaptogenesis.

Zhai Y, Cheng Y, Yuan Y, Meng X, Li Y, Wang Y Cell Death Discov. 2024; 10(1):73.

PMID: 38346981 PMC: 10861539. DOI: 10.1038/s41420-024-01837-3.

Methadone alters transcriptional programs associated with synapse formation in human cortical organoids.

Dwivedi I, Caldwell A, Zhou D, Wu W, Subramaniam S, Haddad G Transl Psychiatry. 2023; 13(1):151.

PMID: 37147277 PMC: 10163238. DOI: 10.1038/s41398-023-02397-3.

References

Pesheva P, Gloor S, Probstmeier R . Tenascin-R as a regulator of CNS glial cell function. Prog Brain Res. 2001; 132:103-14. DOI: 10.1016/S0079-6123(01)32069-1. View

Grammer J, Stewart J, Silverstein R, Pearce S, Tuszynski G, Murphy-Ullrich J . Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. Exp Cell Res. 1999; 249(1):86-101. DOI: 10.1006/excr.1999.4458. View

Meiners S, Geller H . Long and short splice variants of human tenascin differentially regulate neurite outgrowth. Mol Cell Neurosci. 1997; 10(1-2):100-16. DOI: 10.1006/mcne.1997.0643. View

Yunker C, Golembieski W, Lemke N, Schultz C, Cazacu S, Brodie C . SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion. Int J Cancer. 2008; 122(12):2735-43. PMC: 3644882. DOI: 10.1002/ijc.23450. View

Lopes N, Gregg D, Vasudevan S, Hassanain H, Goldschmidt-Clermont P, Kovacic H . Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling. Mol Cell Biol. 2003; 23(15):5401-8. PMC: 165731. DOI: 10.1128/MCB.23.15.5401-5408.2003. View

Guo J, Cheng C, Chen C, Xing X, Xu G, Feng J . Overexpression of Fibulin-5 Attenuates Ischemia/Reperfusion Injury After Middle Cerebral Artery Occlusion in Rats. Mol Neurobiol. 2015; 53(5):3154-3167. DOI: 10.1007/s12035-015-9222-2. View

Shi Q, Bao S, Song L, Wu Q, Bigner D, Hjelmeland A . Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene. 2007; 26(28):4084-94. DOI: 10.1038/sj.onc.1210181. View

Karus M, Denecke B, ffrench-Constant C, Wiese S, Faissner A . The extracellular matrix molecule tenascin C modulates expression levels and territories of key patterning genes during spinal cord astrocyte specification. Development. 2011; 138(24):5321-31. DOI: 10.1242/dev.067413. View

Chiquet-Ehrismann R . Tenascins. Int J Biochem Cell Biol. 2004; 36(6):986-90. DOI: 10.1016/j.biocel.2003.12.002. View

10.

Lin T, Kim G, Chen J, Cheung W, He Y, Hsu C . Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke. 2003; 34(1):177-86. DOI: 10.1161/01.str.0000047100.84604.ba. View

11.

Herold-Mende C, Mueller M, Bonsanto M, Schmitt H, Kunze S, Steiner H . Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer. 2002; 98(3):362-9. DOI: 10.1002/ijc.10233. View

12.

Hu L, Dong M, Zhao H, Xu G, Qin X . Fibulin-5: a novel biomarker for evaluating severity and predicting prognosis in patients with acute intracerebral haemorrhage. Eur J Neurol. 2016; 23(7):1195-201. DOI: 10.1111/ene.13013. View

13.

Kurpad S, Zhao X, Wikstrand C, Batra S, McLendon R, Bigner D . Tumor antigens in astrocytic gliomas. Glia. 1995; 15(3):244-56. DOI: 10.1002/glia.440150306. View

14.

Kong X, Ma W, Li Y, Wang Y, Guan J, Gao J . Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis. Medicine (Baltimore). 2015; 94(32):e1330. PMC: 4616677. DOI: 10.1097/MD.0000000000001330. View

15.

Ruoslahti E . Brain extracellular matrix. Glycobiology. 1996; 6(5):489-92. DOI: 10.1093/glycob/6.5.489. View

16.

Garwood J, Garcion E, Dobbertin A, Heck N, Calco V, ffrench-Constant C . The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor. Eur J Neurosci. 2004; 20(10):2524-40. DOI: 10.1111/j.1460-9568.2004.03727.x. View

17.

Lloyd-Burton S, York E, Anwar M, Vincent A, Roskams A . SPARC regulates microgliosis and functional recovery following cortical ischemia. J Neurosci. 2013; 33(10):4468-81. PMC: 6704956. DOI: 10.1523/JNEUROSCI.3585-12.2013. View

18.

Tran M, Neary J . Purinergic signaling induces thrombospondin-1 expression in astrocytes. Proc Natl Acad Sci U S A. 2006; 103(24):9321-6. PMC: 1482608. DOI: 10.1073/pnas.0603146103. View

19.

Mendis D, Ivy G, Brown I . SC1, a brain extracellular matrix glycoprotein related to SPARC and follistatin, is expressed by rat cerebellar astrocytes following injury and during development. Brain Res. 1996; 730(1-2):95-106. DOI: 10.1016/0006-8993(96)00440-4. View

20.

Deller T, Haas C, Naumann T, Joester A, Faissner A, Frotscher M . Up-regulation of astrocyte-derived tenascin-C correlates with neurite outgrowth in the rat dentate gyrus after unilateral entorhinal cortex lesion. Neuroscience. 1997; 81(3):829-46. DOI: 10.1016/s0306-4522(97)00194-2. View